Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Less investment but more value for Singapore biomedical sector last year

This article was originally published in Scrip

Executive Summary

While Singapore saw a sharp fall in investment commitments in the biomedical manufacturing sector last year, these have shifted to operations and products that are expected to add more value to the economy in the future, the latest figures from the island state's Economic Development Board (EDB) show.

You may also be interested in...

Quick Listen: Scrip’s Five Must-Know Things

Join us for a brief audio roundup of the major developments in the international biopharma industry over the past week, as covered by Scrip's global team.

Astellas Pays $300m+ For iota In ‘Pharma-Plus’ Push

Japanese major builds presence in novel device technology beyond its conventional therapeutics as looks towards a more holistic future of care. 

APAC Podcast: China Vaccines, NASH In Korea, Digital Shifts, India Q2 And Japan Deals

Join the Asia content team for a wide-ranging overview and analysis of developments and trends in the region, including coronavirus vaccines in China, Korean developments in NASH, digital health shifts, Indian corporate performance and Japanese deal trends. 


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts